Clinical Trial
doi: 10.1023/a:1005548619694.Efficacy of methylphenidate among children with autism and symptoms of attention-deficit hyperactivity disorder
Affiliations
- PMID:11055460
- DOI: 10.1023/a:1005548619694
Item in Clipboard
Clinical Trial
Efficacy of methylphenidate among children with autism and symptoms of attention-deficit hyperactivity disorder
B L Handen et al. J Autism Dev Disord.2000 Jun.
Display options
Format
Display options
Format
Abstract
Thirteen children (ages 5.6 to 11.2 years) with autism and symptoms of attention-deficit hyperactivity disorder (ADHD) participated in a double-blind, placebo-controlled crossover study of methylphenidate (0.3 and 0.6 mg/kg per dose). Eight subjects responded positively, based upon a minimum 50% decrease on the Conners Hyperactivity Index. Ratings of stereotypy and inappropriate speech, which are often associated with autistic core features, also decreased. However, no changes were found on the Child Autism Rating Scale, a global assessment of autistic symptomotology. Significant adverse side effects occurred in some children including social withdrawal and irritability, especially at the 0.6 mg/kg dose. Results suggest that methylphenidate can be efficacious for children with autism and ADHD symptoms. However, this group of children seems to be particularly susceptible to adverse side effects.
Similar articles
- A dose-response study of OROS methylphenidate in children with attention-deficit/hyperactivity disorder.Stein MA, Sarampote CS, Waldman ID, Robb AS, Conlon C, Pearl PL, Black DO, Seymour KE, Newcorn JH.Stein MA, et al.Pediatrics. 2003 Nov;112(5):e404. doi: 10.1542/peds.112.5.e404.Pediatrics. 2003.PMID:14595084Clinical Trial.
- Short-term side effects of stimulant medication are increased in preschool children with attention-deficit/hyperactivity disorder: a double-blind placebo-controlled study.Firestone P, Musten LM, Pisterman S, Mercer J, Bennett S.Firestone P, et al.J Child Adolesc Psychopharmacol. 1998;8(1):13-25. doi: 10.1089/cap.1998.8.13.J Child Adolesc Psychopharmacol. 1998.PMID:9639076Clinical Trial.
- Efficacy of a novel biphasic controlled-release methylphenidate formula in adults with attention-deficit/hyperactivity disorder: results of a double-blind, placebo-controlled crossover study.Jain U, Hechtman L, Weiss M, Ahmed TS, Reiz JL, Donnelly GA, Harsanyi Z, Darke AC.Jain U, et al.J Clin Psychiatry. 2007 Feb;68(2):268-77. doi: 10.4088/jcp.v68n0213.J Clin Psychiatry. 2007.PMID:17335326Clinical Trial.
- Immediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults.Epstein T, Patsopoulos NA, Weiser M.Epstein T, et al.Cochrane Database Syst Rev. 2014 Sep 18;(9):CD005041. doi: 10.1002/14651858.CD005041.pub2.Cochrane Database Syst Rev. 2014.Update in:Cochrane Database Syst Rev. 2016 May 26;(5):CD005041. doi: 10.1002/14651858.CD005041.pub3.PMID:25230710Updated.Review.
- [Efficacy and safety of stimulants and non-stimulants in adults with attention deficit hyperactivity disorder (ADHD)].Golubchik P, Sever J, Weizman A.Golubchik P, et al.Harefuah. 2011 Oct;150(10):788-90, 814.Harefuah. 2011.PMID:22111124Review.Hebrew.
Cited by
- Genetic Variations in Attention Deficit Hyperactivity Disorder Subtypes and Treatment Resistant Cases.Unal D, Unal MF, Alikasifoglu M, Cetinkaya A.Unal D, et al.Psychiatry Investig. 2016 Jul;13(4):427-33. doi: 10.4306/pi.2016.13.4.427. Epub 2016 Jul 25.Psychiatry Investig. 2016.PMID:27482244Free PMC article.
- Pharmacological therapies for autism spectrum disorder: a review.LeClerc S, Easley D.LeClerc S, et al.P T. 2015 Jun;40(6):389-97.P T. 2015.PMID:26045648Free PMC article.
- Shank2 Mutant Mice Display Hyperactivity Insensitive to Methylphenidate and Reduced Flexibility in Social Motivation, but Normal Social Recognition.Ey E, Torquet N, de Chaumont F, Lévi-Strauss J, Ferhat AT, Le Sourd AM, Boeckers TM, Bourgeron T.Ey E, et al.Front Mol Neurosci. 2018 Oct 4;11:365. doi: 10.3389/fnmol.2018.00365. eCollection 2018.Front Mol Neurosci. 2018.PMID:30337855Free PMC article.
- Psychiatric symptoms in preschool children with PDD and clinic and comparison samples.Gadow KD, DeVincent CJ, Pomeroy J, Azizian A.Gadow KD, et al.J Autism Dev Disord. 2004 Aug;34(4):379-93. doi: 10.1023/b:jadd.0000037415.21458.93.J Autism Dev Disord. 2004.PMID:15449514
- Current Enlightenment About Etiology and Pharmacological Treatment of Autism Spectrum Disorder.Eissa N, Al-Houqani M, Sadeq A, Ojha SK, Sasse A, Sadek B.Eissa N, et al.Front Neurosci. 2018 May 16;12:304. doi: 10.3389/fnins.2018.00304. eCollection 2018.Front Neurosci. 2018.PMID:29867317Free PMC article.Review.
References
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical